← All organizations
Highest phase reached
Phase 3
First clinical trial
Mar 15, 2018Last known activity
Dec 31, 2025
Acquired by Relmada Therapeutics, Inc. on Dec 1, 2013
Timeline
2010s
- Jun 1, 2012
Medeor Therapeutics, Inc.— Founded
- Dec 1, 2013
Relmada Therapeutics, Inc.— Acquired By
Drugs by trial phase (5 distinct, 7 trials)
Phase 3 (2 own, 0 via acquisition)
Recent trials (11)
- NCT07287670Lead sponsorPhase 2Dec 31, 2025
- NCT06967805Lead sponsorPhase 2May 5, 2025
- NCT06967805OfficialPhase 2May 5, 2025
- NCT06535841OfficialPhase 1Jul 10, 2024
- NCT06535841Lead sponsorPhase 1Jul 10, 2024
- NCT06401213OfficialPhase 1Apr 15, 2024
- NCT06401213Lead sponsorPhase 1Apr 15, 2024
- NCT03605654Lead sponsorPhase 2/Phase 3Dec 31, 2018
- NCT03606746Lead sponsorPhase 2Aug 31, 2018
- NCT03363945Lead sponsorPhase 3Mar 15, 2018
- NCT03363945Study directorPhase 3Mar 15, 2018
Details
- Founded
- San Mateo, CA, US Jun 1, 2012
- Last known activity
- Dec 31, 2025